Articles about Biotechnology – Page 4 of 5

Cancer research startup Juno Therapeutics raises $120M in massive series A financing

In one of the largest series A venture capital deals this year in the biotechnology sector, Seattle-based Juno Therapeutics has… Read More

Tumor paint startup Blaze Bioscience raises $9M to help surgeons pinpoint cancer cells

Blaze Bioscience has raised $9 million in fresh funding from individual investors, money that the Seattle spinoff of the Fred… Read More

Money-losing Dendreon to cut 150 employees in bid to become ‘nimble’ biotech company

Once a rising star in Seattle’s biotechnology community, Dendreon Corp. announced Tuesday that it is reducing its staff by 15… Read More

Cancer research startup Immune Design pulls in $32.5 million, plans to raise more

Immune Design has reeled in $32.5 million in venture capital financing, with plans to raise up to $16.5 million more… Read More

Ex-Dendreon CEO starts healthcare investment fund Alpine BioVentures

Former Dendreon CEO Mitch Gold has partnered with biotechnology stock researcher David Miller to create a new Seattle-based investment firm… Read More

Stem cell biology company Fate Therapeutics files for $69 million IPO

Could this be another example of a startup that got away? Fate Therapeutics, which started in Seattle six years ago… Read More

Nanostring IPO disappoints as shares fall 20% on first day

It was a tough first day on the stock market for Seattle’s NanoString Technologies, with shares falling 19.4 percent on Wednesday as… Read More

Looking to commercialize cancer treatments, Seattle Genetics inks deal with Bayer valued up to $520M

Seattle Genetics has agreed to license its antibody-drug conjugate technology to Bayer HealthCare, a deal that could be worth as much as… Read More

NanoString sets IPO range of $13-$15, plans to trade on Nasdaq under ticker NSTG

Seattle’s NanoString Technologies today set the terms for its upcoming initial public offering, with plans to sell shares in the… Read More

BeatBio gets $2.5M for new ‘super fuel’ that boosts pumping power of heart muscles

BeatBio, a Seattle life sciences startup led by former Vulcan Capital managing director Michael Kranda and former VieVax CTO Gregory… Read More

Theraclone raises $14M to ID rare human antibodies that could be used to fight disease

Seattle biotechnology company Theraclone Sciences has raised an additional $8 million in equity financing and $6 million in debt, bringing… Read More

This ag science startup just scored cash to develop the apple tree of the future

We write about a lot of high-tech stuff here at GeekWire. But here’s a new company that’s bringing a high-tech… Read More

Blaze Bioscience raises $8.5M to help surgeons pinpoint cancer cells with ‘tumor paint’

Seattle biotechnology startup Blaze Bioscience has raised $8.5 million to continue developing technologies that are designed to help surgeons more… Read More

Former oil trader, Yankees part-owner invests in Kineta

Seattle-based biotech upstart Kineta announced a new investment partnership with RLB Holdings, a Connecticut-based investment firm that partially owns the… Read More

Bill Gates backs cancer test startup to create a precise genomic tumor blueprint

Microsoft co-founder Bill Gates is tossing his support behind a Cambridge, Massachusetts company by the name of Foundation Medicine which… Read More

Paul Allen’s Institute for Brain Science to move to Seattle’s South Lake Union area

Seattle’s fast-growing South Lake Union neighborhood is getting another boost — this time from the guy who is largely responsible… Read More

Resolve Therapeutics lands $5.8M to crack the code on Lupus

Resolve Therapeutics, a 2-year-old Seattle biotechnology spin off from the University of Washington, has raised $5.8 million in new financing… Read More

Tech Moves: Amazon hires privacy officer; Blucora bolsters board; CTI’s new hire; and more

TaxACT co-founder Lance Dunn has been appointed to the board of Blucora, the search and tax preparation company formerly known as InfoSpace. Blucora purchased TaxACT… Read More

Dendreon shares sink after plant closure, restructuring

Dendreon, the once-promising Seattle biotechnology company, is taking it on the chin today after announcing a restructuring that will cost… Read More

Tech Moves: Captura co-founder joins Point Inside; ISB; Cypress; Intrepid; etc.

Point Inside, a Seattle startup that specializes in mapping indoor spaces, has named technology veteran Corey Mandell as CTO. Mandell most… Read More

Can ultrasound reduce blood pressure? Kona Medical lands $30M to find out

The Seattle area continues to be a hotbed of innovation in the field of ultrasound technology, with news today that… Read More

Kineta, UW receive biodefense grant to study ways to wipe out deadly viruses like Ebola

The University of Washington, University of Texas Medical Branch and Kineta — a Seattle biotechnology upstart — have received an… Read More

George Rathmann, 1927-2012: Biotech pioneer led Amgen and Icos

George Rathmann, the biotechnology pioneer who served as the first CEO of Amgen and Icos, has died at the age… Read More

Alder BioPharma raises $38M for cancer, migraine research

In one of the largest venture capital rounds in the state so far this year, Bothell’s Alder BioPharmaceuticals has raised $38… Read More

Tech Moves: RealNetworks VP joins Amazon’s Kindle team; etc.

Another day, another executive departure from RealNetworks. Yesterday, we reported that chief financial officer Michael Eggers — a 14-year veteran… Read More

MicroRNA startup Groove Biopharma scores $6 million

It’s been a bit slow in Seattle venture capital circles in the past few months. But some of the region’s… Read More

Venture capitalist Thong Le tapped as chair of biotech group

Thong Le, the managing director of WRF Capital, has been named chairman of the Washington Biotechnology and Biomedical Association. Le… Read More

Theraclone Sciences raises $10M

Theraclone Sciences, a Seattle biotechnology company that’s developing a method to rapidly identify disease-fighting antivbodies, has attracted $10.6 million. Investors… Read More

Atossa raises $6.6M to roll out a ‘Pap test for breast cancer’

Atossa Genetics, which is developing testing technologies to detect the presence of breast cancer, has raised $6.6 million in new… Read More

Allozyne, Poniard to merge

Big news today in Seattle’s biotech industry. Seattle biotechnology upstart Allozyne has entered into a merger agreement with San Francisco’s… Read More